Logos Global Management LP Q2 2021 Filing
Filed August 16, 2021
Portfolio Value
$1.2T
Holdings
57
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (57 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALXOALX ONCOLOGY HLDGS INC | 3,156,981 | $172.6B | 14.62% | |
| 2 | OLMAOLEMA PHARMACEUTICALS INC | 3,743,875 | $104.8B | 8.87% | |
| 3 | DSGNDESIGN THERAPEUTICS INC | 2,732,501 | $54.3B | 4.60% | |
| 4 | VERVVERVE THERAPEUTICS INC | 758,265 | $45.7B | 3.87% | |
| 5 | DYNDYNE THERAPEUTICS INC | 2,054,392 | $43.2B | 3.66% | |
| 6 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 1,100,000 | $40.3B | 3.41% | |
| 7 | KRTXKARUNA THERAPEUTICS INC | 325,000 | $37.0B | 3.14% | |
| 8 | GRPHGRAPHITE BIO INC | 1,070,762 | $32.9B | 2.79% | |
| 9 | TILINSTIL BIO INC | 1,696,850 | $32.8B | 2.78% | |
| 10 | CMPSCOMPASS PATHWAYS PLC | 850,000 | $32.4B | 2.75% | |
| 11 | RAPTEURRAPT THERAPEUTICS INC | 1,020,000 | $32.4B | 2.75% | Call |
| 12 | NKTXNKARTA INC | 1,002,382 | $31.8B | 2.69% | |
| 13 | —TURNING POINT THERAPEUTICS I | 400,000 | $31.2B | 2.64% | |
| 14 | —KINNATE BIOPHARMA INC | 1,329,602 | $31.0B | 2.62% | |
| 15 | —FORMA THERAPEUTICS HLDGS INC | 1,215,000 | $30.2B | 2.56% | |
| 16 | IOVAIOVANCE BIOTHERAPEUTICS INC | 1,125,000 | $29.3B | 2.48% | |
| 17 | IPSCCENTURY THERAPEUTICS INC | 989,095 | $29.0B | 2.46% | |
| 18 | CYTKCYTOKINETICS INC | 1,400,000 | $27.7B | 2.35% | |
| 19 | EWTXEDGEWISE THERAPEUTICS INC | 1,231,812 | $26.3B | 2.22% | |
| 20 | APLSAPELLIS PHARMACEUTICALS INC | 350,000 | $22.1B | 1.87% | |
| 21 | BCYCBICYCLE THERAPEUTICS PLC | 715,000 | $21.7B | 1.84% | |
| 22 | CNTACENTESSA PHARMACEUTICALS PLC | 939,545 | $20.9B | 1.77% | |
| 23 | BMEABIOMEA FUSION INC | 1,162,320 | $18.1B | 1.54% | |
| 24 | OPHTEURIVERIC BIO INC | 2,500,000 | $15.8B | 1.34% | |
| 25 | GHRSGH RESEARCH PLC | 724,333 | $15.7B | 1.33% | |
| 26 | —ATHIRA PHARMA INC | 1,410,812 | $14.4B | 1.22% | |
| 27 | JANXJANUX THERAPEUTICS INC | 547,122 | $13.7B | 1.16% | |
| 28 | KZRKEZAR LIFE SCIENCES INC | 2,300,000 | $12.5B | 1.06% | |
| 29 | —RAIN THERAPEUTICS INC | 780,331 | $12.1B | 1.03% | |
| 30 | ACRSACLARIS THERAPEUTICS INC | 675,000 | $11.9B | 1.00% | |
| 31 | COGTCOGENT BIOSCIENCES INC | 1,420,500 | $11.5B | 0.98% | |
| 32 | PRLDPRELUDE THERAPEUTICS INC | 400,000 | $11.5B | 0.97% | |
| 33 | KNSAKINIKSA PHARMACEUTICALS LTD | 800,000 | $11.1B | 0.94% | |
| 34 | —HARPOON THERAPEUTICS INC | 800,000 | $11.1B | 0.94% | |
| 35 | —LANDOS BIOPHARMA INC | 899,106 | $10.4B | 0.88% | |
| 36 | RPTXREPARE THERAPEUTICS INC | 330,000 | $10.3B | 0.87% | |
| 37 | —TALARIS THERAPEUTICS INC | 507,923 | $7.5B | 0.63% | |
| 38 | CGEMCULLINAN ONCOLOGY INC | 288,458 | $7.4B | 0.63% | |
| 39 | PMVPPMV PHARMACEUTICALS INC | 206,564 | $7.1B | 0.60% | |
| 40 | GLUEMONTE ROSA THERAPEUTICS INC | 300,000 | $6.8B | 0.58% | |
| 41 | —CATABASIS PHARMACEUTICALS IN | 3,190,000 | $6.7B | 0.57% | |
| 42 | —ASLAN PHARMACEUTICALS LTD | 2,000,000 | $6.6B | 0.56% | |
| 43 | ALGSALIGOS THERAPEUTICS INC | 212,785 | $4.3B | 0.37% | |
| 44 | CCCCC4 THERAPEUTICS INC | 112,928 | $4.3B | 0.36% | |
| 45 | —IKENA ONCOLOGY INC | 299,853 | $4.2B | 0.36% | |
| 46 | ANNXANNEXON INC | 159,622 | $3.6B | 0.30% | |
| 47 | —BCTG ACQUISITION CORP | 200,000 | $2.3B | 0.19% | |
| 48 | —ARYA SCIENCES ACQU CORP IV | 200,000 | $2.1B | 0.18% | |
| 49 | ELDNELEDON PHARMACEUTICALS INC | 224,071 | $1.8B | 0.15% | |
| 50 | PASGPASSAGE BIO INC | 125,010 | $1.7B | 0.14% | |
| 51 | —FS DEVELOPMENT CORP II | 123,543 | $1.2B | 0.10% | |
| 52 | —HEALTH SCIENCES ACQ CORP 2 | 100,000 | $1.0B | 0.09% | |
| 53 | —RESEARCH ALLIANCE CORP II | 100,000 | $1.0B | 0.09% | |
| 54 | DAWNDAY ONE BIOPHARMACEUTICALS I | 37,069 | $844.0M | 0.07% | |
| 55 | MLTXHELIX ACQUISITION CORP | 50,000 | $518.0M | 0.04% | |
| 56 | NUVB/WSNUVATION BIO INC | 66,666 | $173.0M | 0.01% | |
| 57 | MREOMEREO BIOPHARMA GROUP PLC | 46,984 | $149.0M | 0.01% |